Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HL-1186 Tablets for Postoperative Abdominal Pain
CTR20261424Phase 3Active
- Sponsor
- Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of HL-1186 in postoperative pain, sponsored by Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.. Started Apr 2026; status: active.
02
Drugs
HL-1186
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20261424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20261424.